Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

5.82
Delayed Data
As of Jul 31
 +0.06 / +1.04%
Today’s Change
5.71
Today|||52-Week Range
10.26
-24.51%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Mclaughlin John Peter
President & Chief Executive Officer
Gift1/28/2015129,201$7.62$984.5K-23.62%
Stone Christopher Lewis
General Counsel, Secretary & Vice President
Gift1/28/201533,110$7.62$252.3K-23.62%
Garcia Peter S
Chief Financial Officer & Vice President
Gift1/28/201532,847$7.62$250.3K-23.62%
Hart Danny J Jr
Vice President-Business Development
Gift1/28/201528,543$7.62$217.5K-23.62%
Sandman Paul W
Director
Gift5/28/201522,059$6.80$150.0K-14.41%
Selick Harold E
Director
Gift5/28/201522,059$6.80$150.0K-14.41%
Lindell Jody S
Director
Gift5/28/201522,059$6.80$150.0K-14.41%
Gryska David W
Director
Gift5/28/201522,059$6.80$150.0K-14.41%
Montez David
Chief Accounting Officer & Controller
Gift1/28/201511,961$7.62$91.1K-23.62%
Pietzke Steffen
Chief Accounting Officer & Controller
Gift7/06/201514,748$6.18$91.1K-5.83%
Page of 2